Cannabis Report
Home > Boards > US OTC > Biotechs > Nutra Pharma Corp. (NPHC)

I like this in the article...

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
fly_fisherman Member Profile
Member Level 
Followed By 481
Posts 23,110
Boards Moderated 2
Alias Born 08/12/10
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 8/17/2018 4:10:21 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 8/14/2018 4:27:03 PM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 6/29/2018 4:31:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/26/2018 5:02:05 PM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 6/6/2018 4:33:46 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/21/2018 4:33:40 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 5/15/2018 5:36:51 PM
Annual Report (10-k) Edgar (US Regulatory) - 4/17/2018 3:16:52 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) Edgar (US Regulatory) - 4/2/2018 4:51:41 PM
Information Statement - All Other (definitive) (def 14c) Edgar (US Regulatory) - 3/20/2018 4:37:49 PM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 3/8/2018 4:26:39 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/7/2018 4:13:01 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/5/2018 11:54:49 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/2/2018 9:03:44 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/20/2017 4:10:38 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 11/14/2017 4:18:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/3/2017 4:05:32 PM
fly_fisherman Member Level  Thursday, 03/08/18 08:19:44 PM
Re: lasko post# 31904
Post # of 39742 
I like this in the article...


This will allow us to fulfill our commitments to our noteholders as well as finalize legitimate, long-term and non-toxic financing to move the Company forward. The use of this financing includes retail marketing for our OTC products as well as clinical research for our drug products for the treatment of autoimmune diseases and viruses,” he concluded.

It did not mention J.V. or partnerships. I do believe that is yet to come folks in addition to this!!!!


ALL POSTS are just my opinion! Never BUY/SELL stock based on only them! Perform your own DD and make your own decision!
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist